HIV and ADAR Editing
HIV and ADAR Editing
批准号:
8481715
负责人:
MARIE-LOUISE HAMMARSKJOLD
金额:
$27.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-05 至 2015-03-31
关键词:
ADAR1AdenosineAffectAntisense RNACellsCodeDRADA2b proteinDeaminationDevelopmentDouble-Stranded RNAEnzymesEventEvolutionFamilyGenesGenetic TranscriptionGenomeHIVHIV-1HumanHybridsImmuneInosineLeadMalignant NeoplasmsMason-Pfizer monkey virusMediatingMessenger RNAModelingMolecularMutationNatural ImmunityNucleic AcidsPathway interactionsPatternPhysiologicalPlayProteinsPublishingRNARNA EditingRNA InterferenceRegulationReportingRoleTestingTherapeuticViralVirusVirus ReplicationdsRNA adenosine deaminasehuman diseasemRNA Exportnovelpublic health relevanceresearch studystemtraffickingviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Proteins of the ADAR (adenosine deaminases acting on RNA) family catalyze the most common RNA editing event in mRNA in human cells, A to I deamination. ADAR specifically edits residues in regions of double stranded RNA. ADAR activity results in selective editing in shorter, imperfect stems, whereas long perfectly double stranded regions are usually more extensively edited. ADAR activity plays an important physiological role and has been implicated in cancer, development and RNAi. ADAR proteins have also been shown to be important factors in the replication of many viruses. However, only a few studies to date have dealt with the effects of ADAR genes on HIV replication. The effects of ADAR1 on HIV1 remain controversial, with reports of both positive and negative effects, whereas there is only one published study of the effects of ADAR2. The molecular mechanism underlying ADAR effects remain to be elucidated. The ADAR genes were likely generated from a common ancestor that also gave rise to another family of editing enzymes, the ApoBec proteins. These proteins have recently been proposed to potentially play a role in HIV evolution and immune evasion, in addition to their roles in HIV restriction. Our hypothesis is that ADAR proteins are also used by HIV, not only for regulation, but also for evolution and immune evasion. We thus propose to initiate studies to systematically and extensively analyze the effects of ADAR on HIV. First we will determine how ADAR edits stem regions in the HIV mRNAs and how this relates to RNA trafficking pathways. Secondly, we will analyze ADAR editing of HIV sense/antisense RNA hybrids, using a therapeutic HIV antisense RNA as a model. Specific Aim 1: To analyze how ADAR1 and ADAR2 function to edit stem-loop regions in HIV mRNAs and if differential editing occurs depending on the mRNA export pathway. Specific Aim 2: To analyze how ADAR affects antisense RNA mediated inhibition and RNA editing in HIV antisense target regions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Factors That Restrict HIV mRNA With Retained Introns
-
批准号:10480987
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Effects of HIV Rev on Host Cell Gene Expression
-
批准号:10546602
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Host Factors That Restrict HIV mRNA With Retained Introns
-
批准号:10553285
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Effects of HIV Rev on Host Cell Gene Expression
-
批准号:10673153
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9475762
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Role of HIV Rev in Reactivation from Latency
-
批准号:9534516
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:10132254
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9334986
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9903256
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8465556
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8858647
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8915864
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8708170
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:9069936
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV and ADAR Editing
-
批准号:8646880
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:8217116
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:7786965
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:8019508
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway
-
批准号:7758737
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway
-
批准号:7685081
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: